DK386882A - Fremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents
Fremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf Download PDFInfo
- Publication number
- DK386882A DK386882A DK386882A DK386882A DK386882A DK 386882 A DK386882 A DK 386882A DK 386882 A DK386882 A DK 386882A DK 386882 A DK386882 A DK 386882A DK 386882 A DK386882 A DK 386882A
- Authority
- DK
- Denmark
- Prior art keywords
- pyridyl
- amino
- preparing
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29822481A | 1981-08-31 | 1981-08-31 | |
| US29822481 | 1981-08-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK386882A true DK386882A (da) | 1983-04-07 |
| DK160303B DK160303B (da) | 1991-02-25 |
| DK160303C DK160303C (da) | 1991-08-05 |
Family
ID=23149579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK386882A DK160303C (da) | 1981-08-31 | 1982-08-30 | Analogifremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf samt 5'-(2-halogen-4-pyridyl)-1',2',4',-triazol-forbindelser til anvendelse ved fremgangsmaaden |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0074229B1 (da) |
| JP (1) | JPS5846083A (da) |
| KR (1) | KR860000103B1 (da) |
| AR (1) | AR230994A1 (da) |
| AT (1) | ATE19078T1 (da) |
| AU (1) | AU534063B2 (da) |
| CA (1) | CA1177485A (da) |
| DE (1) | DE3270423D1 (da) |
| DK (1) | DK160303C (da) |
| ES (1) | ES8308324A1 (da) |
| FI (1) | FI78085C (da) |
| GR (1) | GR77241B (da) |
| HU (1) | HU188328B (da) |
| IE (1) | IE53586B1 (da) |
| IL (1) | IL66673A (da) |
| PH (1) | PH17423A (da) |
| PL (1) | PL134315B1 (da) |
| PT (1) | PT75481A (da) |
| YU (1) | YU42795B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004229392A1 (en) | 2003-04-09 | 2004-10-28 | Exelixis, Inc. | Tie-2 modulators and methods of use |
| DK2427436T3 (da) | 2009-05-07 | 2013-04-02 | Gruenenthal Gmbh | Substituerede aromatiske carboxamid og urea derivater som vanilloidreceptorligander. |
| EP2431035A1 (en) * | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors |
| JP2023509452A (ja) | 2020-01-03 | 2023-03-08 | バーグ エルエルシー | がんを処置するためのｕｂｅ２ｋモジュレータとしての多環式アミド |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4276297A (en) * | 1979-06-18 | 1981-06-30 | Pfizer Inc. | Pyridylaminotriazole therapeutic agents |
-
1982
- 1982-08-25 AR AR290432A patent/AR230994A1/es active
- 1982-08-27 IE IE2087/82A patent/IE53586B1/en unknown
- 1982-08-27 DE DE8282304531T patent/DE3270423D1/de not_active Expired
- 1982-08-27 AT AT82304531T patent/ATE19078T1/de active
- 1982-08-27 GR GR69141A patent/GR77241B/el unknown
- 1982-08-27 CA CA000410270A patent/CA1177485A/en not_active Expired
- 1982-08-27 EP EP82304531A patent/EP0074229B1/en not_active Expired
- 1982-08-30 PH PH27793A patent/PH17423A/en unknown
- 1982-08-30 KR KR8203906A patent/KR860000103B1/ko active
- 1982-08-30 IL IL66673A patent/IL66673A/xx unknown
- 1982-08-30 JP JP57150638A patent/JPS5846083A/ja active Pending
- 1982-08-30 FI FI822999A patent/FI78085C/fi not_active IP Right Cessation
- 1982-08-30 DK DK386882A patent/DK160303C/da not_active IP Right Cessation
- 1982-08-30 HU HU822780A patent/HU188328B/hu unknown
- 1982-08-30 AU AU87841/82A patent/AU534063B2/en not_active Ceased
- 1982-08-30 PT PT75481A patent/PT75481A/pt not_active IP Right Cessation
- 1982-08-30 ES ES515366A patent/ES8308324A1/es not_active Expired
- 1982-08-31 PL PL1982238095A patent/PL134315B1/pl unknown
- 1982-08-31 YU YU1963/82A patent/YU42795B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI78085B (fi) | 1989-02-28 |
| EP0074229B1 (en) | 1986-04-09 |
| YU196382A (en) | 1985-03-20 |
| KR860000103B1 (ko) | 1986-02-19 |
| FI822999A0 (fi) | 1982-08-30 |
| HU188328B (en) | 1986-04-28 |
| EP0074229A1 (en) | 1983-03-16 |
| YU42795B (en) | 1988-12-31 |
| PT75481A (en) | 1982-09-01 |
| PL134315B1 (en) | 1985-08-31 |
| PH17423A (en) | 1984-08-08 |
| DK160303B (da) | 1991-02-25 |
| IL66673A (en) | 1986-04-29 |
| KR840001155A (ko) | 1984-03-28 |
| AU8784182A (en) | 1983-03-31 |
| JPS5846083A (ja) | 1983-03-17 |
| IE53586B1 (en) | 1988-12-21 |
| IE822087L (en) | 1983-02-28 |
| ES515366A0 (es) | 1983-08-16 |
| CA1177485A (en) | 1984-11-06 |
| DE3270423D1 (en) | 1986-05-15 |
| GR77241B (da) | 1984-09-11 |
| DK160303C (da) | 1991-08-05 |
| ES8308324A1 (es) | 1983-08-16 |
| FI78085C (fi) | 1989-06-12 |
| ATE19078T1 (de) | 1986-04-15 |
| AR230994A1 (es) | 1984-08-31 |
| IL66673A0 (en) | 1982-12-31 |
| FI822999L (fi) | 1983-03-01 |
| AU534063B2 (en) | 1984-01-05 |
| PL238095A1 (en) | 1984-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK74282A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK462480A (da) | Fremgangsmaade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenaminderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK462380A (da) | Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf | |
| DK106882A (da) | Fremgangsmaade til fremstilling af 3,4-dihydro-5h-2,3-benzodiazepin-derivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK337383A (da) | Fremgangsmaade til fremstilling af 4-amino-6,7-dimethoxyquinolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148795C (da) | Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK552581A (da) | Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK413783A (da) | Fremgangsmaade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf | |
| DK453181A (da) | Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf | |
| DK160421C (da) | Analogifremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf | |
| DK224281A (da) | Fremgangsmaade til fremstilling af 2,2-dimethylpenam-3-carboxylsyre-1,1-dioxid-forbindelser eller salte deraf | |
| DK157451C (da) | Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK321482A (da) | Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK98383A (da) | Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK165790C (da) | Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf | |
| DK150597C (da) | Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf | |
| DK15282A (da) | Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK386882A (da) | Fremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148281C (da) | Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf | |
| DK275383A (da) | Fremgangsmaade til fremstilling af 1-(2-heterocyclyl-2-(5-chlor-2-pyridyl)-2-hydroxy-ethyl)-1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160875C (da) | Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK155081A (da) | Fremgangsmaade til fremstilling af 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensyre eller salte heraf | |
| DK152754C (da) | Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK586284D0 (da) | Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel | |
| DK398283D0 (da) | Fremgangsmade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |